Department of Biochemistry, Université de Montréal, Montreal, Quebec H3T 1J4, Canada.
J Mol Cell Cardiol. 2013 Sep;62:58-68. doi: 10.1016/j.yjmcc.2013.05.003. Epub 2013 May 17.
At the cell surface, βARs and endothelin receptors can regulate nitric oxide (NO) production. β-adrenergic receptors (βARs) and type B endothelin receptors (ETB) are present in cardiac nuclear membranes and regulate transcription. The present study investigated the role of the NO pathway in the regulation of gene transcription by these nuclear G protein-coupled receptors. Nitric oxide production and transcription initiation were measured in nuclei isolated from the adult rat heart. The cell-permeable fluorescent dye 4,5-diaminofluorescein diacetate (DAF2 DA) was used to provide a direct assessment of nitric oxide release. Both isoproterenol and endothelin increased NO production in isolated nuclei. Furthermore, a β3AR-selective agonist, BRL 37344, increased NO synthesis whereas the β1AR-selective agonist xamoterol did not. Isoproterenol increased, whereas ET-1 reduced, de novo transcription. The NO synthase inhibitor l-NAME prevented isoproterenol from increasing either NO production or de novo transcription. l-NAME also blocked ET-1-induced NO-production but did not alter the suppression of transcription initiation by ET-1. Inhibition of the cGMP-dependent protein kinase (PKG) using KT5823 also blocked the ability of isoproterenol to increase transcription initiation. Furthermore, immunoblotting revealed eNOS, but not nNOS, in isolated nuclei. Finally, caged, cell-permeable isoproterenol and endothelin-1 analogs were used to selectively activate intracellular β-adrenergic and endothelin receptors in intact adult cardiomyocytes. Intracellular release of caged ET-1 or isoproterenol analogs increased NO production in intact adult cardiomyocytes. Hence, activation of the NO synthase/guanylyl cyclase/PKG pathway is necessary for nuclear β3ARs to increase de novo transcription. Furthermore, we have demonstrated the potential utility of caged receptor ligands in selectively modulating signaling via endogenous intracellular G protein-coupled receptors.
在细胞表面,βAR 和内皮素受体可以调节一氧化氮 (NO) 的产生。β-肾上腺素能受体 (βAR) 和 B 型内皮素受体 (ETB) 存在于心脏核膜中,并调节转录。本研究探讨了 NO 途径在这些核 G 蛋白偶联受体调节基因转录中的作用。在从成年大鼠心脏分离的核中测量了 NO 产生和转录起始。细胞通透性荧光染料 4,5-二氨基荧光素二乙酸酯 (DAF2 DA) 用于直接评估一氧化氮的释放。异丙肾上腺素和内皮素都增加了分离核中的 NO 产生。此外,β3AR 选择性激动剂 BRL 37344 增加了 NO 合成,而 β1AR 选择性激动剂 xamoterol 则没有。异丙肾上腺素增加,而 ET-1 减少,从头转录。NO 合酶抑制剂 l-NAME 阻止异丙肾上腺素增加 NO 产生或从头转录。l-NAME 还阻断了 ET-1 诱导的 NO 产生,但没有改变 ET-1 对转录起始的抑制作用。使用 KT5823 抑制 cGMP 依赖性蛋白激酶 (PKG) 也阻断了异丙肾上腺素增加转录起始的能力。此外,免疫印迹显示 eNOS,但不是 nNOS,在分离的核中。最后,使用笼状、细胞通透性的异丙肾上腺素和内皮素-1 类似物选择性地激活完整成年心肌细胞内的细胞内 β-肾上腺素能和内皮素受体。笼状 ET-1 或异丙肾上腺素类似物的细胞内释放增加了完整成年心肌细胞中的 NO 产生。因此,NO 合酶/鸟苷酸环化酶/PKG 途径的激活是核β3AR 增加从头转录所必需的。此外,我们已经证明了笼状受体配体在选择性调节内源性细胞内 G 蛋白偶联受体信号方面的潜在用途。